- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07942597
An AI-Powered Chatbot Targeting Nicotine and Cannabis Dual Vaping Cessation in Young Adults (D-QUIT)
An AI-Powered Chatbot Targeting Nicotine and Cannabis Dual Vaping Cessation in Young Adults (Aim 2)
A pilot study evaluates the feasibility and acceptability of D-QUIT, an AI-powered smartphone app providing personalized behavioral support for nicotine and cannabis vaping cessation among young adults.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Primary Objective:
I. To evaluate the feasibility and acceptability of D-QUIT, a smartphone app enhanced by an AI chatbot for vaping cessation.
Secondary Objective:
I. To assess intervention engagement and preliminary vaping cessation outcomes.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Nhung Nguyen, PhD PharmD
- Telefonnummer: 877-827-3222
- E-post: VapingStudy@ucsf.edu
Studiesteder
-
-
California
-
San Francisco, California, Forente stater, 94143
- University of California, San Francisco
-
Ta kontakt med:
- Nhung Nguyen, PhD PharmD
- Telefonnummer: 877-827-3222
- E-post: VapingStudy@ucsf.edu
-
Hovedetterforsker:
- Nhung Nguyen, PhD PharmD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Speak English.
- Ages 18-29.
- Live in California.
- Own a smartphone.
- Report vaping nicotine frequently (20+ days during the past month).
- Report vaping cannabis at least weekly.
- Intent to quit vaping nicotine in the next 30 days.
Exclusion Criteria:
- Younger than 18 years or older than 29 years of age.
- unable to read, speak, or understand English.
- Unwilling or unable to participate or give informed consent.
- Do not own a smartphone.
- have not vaped nicotine at least 20 days in the past month.
- Have not vaped cannabis at least weekly.
- Not thinking about quitting vaping within the next 30 days.
- Do not live in California.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: D-QUIT Pilot Intervention
Participants will use the D-QUIT smartphone app for 6 weeks to support their goals for quitting or reducing nicotine and cannabis vaping. During the 2 weeks before their nicotine vaping quit date, participants will receive app notifications to help identify vaping patterns and triggers, set goals, and learn coping skills. Beginning on the quit date, participants will receive tailored messages for 4 weeks with tips for managing withdrawal and support based on their vaping goals. Participants will also be encouraged to interact with the chatbot for 5-15 minutes daily and complete brief morning and end-of-day check-ins about vaping, cravings, mood, and withdrawal symptoms. At the end of the intervention, participants will complete a survey, and a subset will be invited to an interview to provide feedback on D-QUIT. |
A Smartphone App Enhanced by AI Chatbot Delivered Remotely via Mobile Phone Feasibility and Acceptability Measures administered at the end of 6-week intervention. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of the D-QUIT Smartphone App
Tidsramme: At Week 6
|
Feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM). Each item is rated on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree). Higher item scores indicate greater perceived feasibility of the intervention. Descriptive data will be reported. |
At Week 6
|
|
Acceptability of the D-QUIT Smartphone App
Tidsramme: At Week 6
|
Acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM). Each item is rated on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree). Higher item scores indicate greater acceptability of the intervention. Descriptive data will be reported. |
At Week 6
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Intervention Engagement
Tidsramme: At Week 6
|
Intervention engagement will be assessed using participants' duration of D-QUIT use (0-6 weeks) and the frequency of chatbot use during the intervention. Descriptive data will be reported. |
At Week 6
|
|
Preliminary Vaping-Cessation Outcomes
Tidsramme: At Week 6
|
Preliminary vaping-cessation outcomes will be assessed using self-reported measures of nicotine and cannabis vaping, including the number of days vaped in the past 30 days or the number of quit attempts since starting D-QUIT. Use of other nicotine/tobacco and cannabis products will also be assessed. Descriptive data will be reported. |
At Week 6
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Nhung Nguyen, PhD PharmD, University of California, San Francisco
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Oppførsel
- Røyking
- Helseatferd
- Marihuana bruk
- Røyking, ikke-tobakksprodukter
- Vaping
- Røykeslutt
- Marihuana røyking
- Helsevesenets kvalitet, tilgang og evaluering
- Undersøkelsesteknikker
- Epidemiologiske metoder
- Datainnsamling
- Helsevesenets evalueringsmekanismer
- Kvalitet på helsehjelpen
- Folkehelse
- Miljø og folkehelse
- Undersøkelser og spørreskjemaer
Andre studie-ID-numre
- 26634
- T36IP10313 (Annet stipend/finansieringsnummer: The California Tobacco Related Disease Research Program (TRDRP))
- NCI-2026-08289 (Registeridentifikator: NCI Clinical Trials Reporting System (CTRP))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .